Contents

Search


hereditary neoplastic syndrome; cancer susceptibility syndrome

Management: - genetic counseling - aggressive screening for cancer

Specific

ataxia telangiectasia; Louis-Bar syndrome Bannayan-Zonana syndrome, Ruvalcaba-Riley-Smith syndrome; Ruvalcaba-Myhre-Smith syndrome; Bannayan-Riley-Ruvalcaba syndrome Carney complex Carney triad de Sanctis-Cacchione syndrome (xerodermic idiocy) Denys-Drash syndrome dysplastic nevus syndrome (inherited familial atypical mole & melanoma syndrome) familial breast-ovarian cancer familial cylindromatosis; Ancell-Spiegler cylindromas; dermal eccrine cylindromatosis; turban tumor syndrome familial lipoma syndrome familial medullary thyroid carcinoma familial nonchromaffin paraganglioma Fanconi anemia Frasier syndrome hereditary colon cancer syndrome intestinal polyposis syndrome Li-Fraumeni syndrome lymphangioleiomyomatosis melanoma-astrocytoma syndrome multiple endocrine neoplasia (MEN) multiple familial trichoepithelioma type 1; epithelioma adenoides cysticum of Brooke; hereditary multiple benign cystic epithelioma; Brooke-Fordyce trichoepitheliomas multiple mucosal neuromas syndrome neurofibromatosis (von Recklinghausen's disease) nevoid basal cell carcinoma syndrome; basal cell nevus syndrome; Gorlin-Goltz syndrome phakomatosis (phacomatosis) Reed syndrome schwannomatosis (congenital cutaneous neurilemmomatosis) Spiegler-Brooke syndrome tuberous sclerosis (Bourneville disease, epiloia) von Hippel-Lindau disease WAGR syndrome; Wilms tumor-aniridia-genitourinary anomalies-mental retardation xeroderma pigmentosum

General

genetic syndrome (multisystem disorder) neoplasm; tumor

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 18. American College of Physicians, Philadelphia 2009, 2012, 2018.
  2. Lindor NM, McMaster ML, Lindor CJ et al Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr. 2008;(38):1-93 PMID: 18559331
  3. ARUP Consult: Hereditary Cancer Panel https://arupconsult.com/ati/hereditary-cancer-panel